These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20848485)

  • 1. Peripheral regulatory T cells and serum transforming growth factor-β: relationship with clinical response to infliximab in Crohn's disease.
    Di Sabatino A; Biancheri P; Piconese S; Rosado MM; Ardizzone S; Rovedatti L; Ubezio C; Massari A; Sampietro GM; Foschi D; Porro GB; Colombo MP; Carsetti R; MacDonald TT; Corazza GR
    Inflamm Bowel Dis; 2010 Nov; 16(11):1891-7. PubMed ID: 20848485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heightened Expression of CD39 by Regulatory T Lymphocytes Is Associated with Therapeutic Remission in Inflammatory Bowel Disease.
    Gibson DJ; Elliott L; McDermott E; Tosetto M; Keegan D; Byrne K; Martin ST; Rispens T; Cullen G; Mulcahy HE; Cheifetz AS; Moss AC; Robson SC; Doherty GA; Ryan EJ
    Inflamm Bowel Dis; 2015 Dec; 21(12):2806-14. PubMed ID: 26332314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy with anti-TNFα antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases.
    Boschetti G; Nancey S; Sardi F; Roblin X; Flourié B; Kaiserlian D
    Inflamm Bowel Dis; 2011 Jan; 17(1):160-70. PubMed ID: 20848510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different patterns of serum interleukin 10 response to treatment with anti-tumor necrosis factor alpha antibody (infliximab) in Crohn's disease.
    Detková Z; Kupcová V; Príkazská M; Turecký L; Weissová S; Jahnová E
    Physiol Res; 2003; 52(1):95-100. PubMed ID: 12625813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti tumour necrosis-alpha therapy increases the number of FOXP3 regulatory T cells in children affected by Crohn's disease.
    Ricciardelli I; Lindley KJ; Londei M; Quaratino S
    Immunology; 2008 Oct; 125(2):178-83. PubMed ID: 18422560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease.
    Martínez-Borra J; López-Larrea C; González S; Fuentes D; Dieguez A; Deschamps EM; Pérez-Pariente JM; López-Vázquez A; de Francisco R; Rodrigo L
    Am J Gastroenterol; 2002 Sep; 97(9):2350-6. PubMed ID: 12358255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrete changes in circulating regulatory T cells during infliximab treatment of Crohn's disease.
    Hvas CL; Kelsen J; Agnholt J; Dige A; Christensen LA; Dahlerup JF
    Autoimmunity; 2010 Jun; 43(4):325-33. PubMed ID: 20298123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic function and IgM-memory B cells in Crohn's disease patients treated with infliximab.
    Di Sabatino A; Rosado MM; Cazzola P; Biancheri P; Tinozzi FP; Laera MR; Cantoro L; Vanoli A; Carsetti R; Corazza GR
    Inflamm Bowel Dis; 2008 May; 14(5):591-6. PubMed ID: 18240280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn's disease.
    Juanola O; Moratalla A; Gutiérrez A; Sempere L; Zapater P; Giménez P; Almenta I; Peiró G; González-Navajas JM; Such JF; Francés R
    J Gastroenterol; 2015 Jul; 50(7):758-68. PubMed ID: 25500977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal changes of Foxp3 expression in blood and intestinal mucosa in IBD patients responding to infliximab.
    Li Z; Arijs I; De Hertogh G; Vermeire S; Noman M; Bullens D; Coorevits L; Sagaert X; Schuit F; Rutgeerts P; Ceuppens JL; Van Assche G
    Inflamm Bowel Dis; 2010 Aug; 16(8):1299-310. PubMed ID: 20196149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Treg cells and TGF-β1 in patients with systemic lupus erythematosus: a possible relation with lupus nephritis.
    Xing Q; Su H; Cui J; Wang B
    Immunol Invest; 2012; 41(1):15-27. PubMed ID: 21563925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tumor necrosis factor-α blockade on mucosal addressin cell-adhesion molecule-1 in Crohn's disease.
    Biancheri P; Di Sabatino A; Rovedatti L; Giuffrida P; Calarota SA; Vetrano S; Vidali F; Pasini A; Danese S; Corazza GR; MacDonald TT
    Inflamm Bowel Dis; 2013 Feb; 19(2):259-64. PubMed ID: 23328772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of house dust mite immunotherapy on transforming growth factor beta1-producing T cells in asthmatic children.
    Ajduk J; Marinic I; Aberle N; Rabatic S; Gagro A
    Ann Allergy Asthma Immunol; 2008 Apr; 100(4):314-22. PubMed ID: 18450115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The comparison of CD4(+) CD25(+) Treg, IL-10 and TGF-beta from lymph and blood in bronchial asthmatic rat and the effect of dexamethasone on it].
    Zhao ZX; Feng XB; Shi T; Yang C; Zhang LX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Mar; 26(3):238-41. PubMed ID: 20230687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating level of CD4+ CD25+ FOXP3+ T cells in patients with chronic urticaria.
    Arshi S; Babaie D; Nabavi M; Tebianian M; Ghalehbaghi B; Jalali F; Ahmadvand A; Gholami R
    Int J Dermatol; 2014 Dec; 53(12):e561-6. PubMed ID: 25311400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease.
    Gao Q; Hogezand RA; Lamers CB; Verspaget HW
    Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.
    Wang D; Huang S; Yuan X; Liang J; Xu R; Yao G; Feng X; Sun L
    Cell Mol Immunol; 2017 May; 14(5):423-431. PubMed ID: 26435067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of TIM-3, Human β-defensin-2, and FOXP3 and Correlation with Disease Activity in Pediatric Crohn's Disease with Infliximab Therapy.
    Kim MJ; Lee WY; Choe YH
    Gut Liver; 2015 May; 9(3):370-80. PubMed ID: 25071071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association of Breg cells and Treg cells with the clinical effects of Infliximab in the treatment of Chinese patients with Crohn's disease].
    Lin QR; Xia XP; Cai XN; Hu DY; Shao XX; Xia SL; Jiang Y
    Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3303-3308. PubMed ID: 33202491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.